A genetic analysis involving about 200 people with acute myeloid leukemia has cataloged most of the mutations associated with the blood cancer, researchers reported in The New England Journal of Medicine. Leukemia cells averaged 13 mutations, many fewer than are seen with solid tumor cancers, according to researchers from Washington University in St. Louis. Access to the "genetic playbook" could help guide treatment decisions, a researcher said.

Related Summaries